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Breed- and prion protein (PRNP) genotype-related disease phenotype variability has been
observed in sheep infected with the 87V murine scrapie strain. Therefore, the stability of this
strain was tested by inoculating sheep-derived 87V brain material back into VM mice. As some
sheep-adapted 87V disease phenotypes were reminiscent of CH1641 scrapie, transgenic mice
(Tg338) expressing ovine prion protein (PrP) were inoculated with the same sheep-derived 87V
sources and with CH1641. Although at first passage in VM mice the sheep-derived 87V
sources showed some divergence from the murine 87V control, all the characteristics of murine
87V infection were recovered at second passage from all sheep sources. These included 100 %
attack rates and indistinguishable survival times, lesion profiles, immunohistochemical features
of disease-associated PrP accumulation in the brain and PrP biochemical properties. All sheep-
derived 87V sources, as well as CH1641, were transmitted to Tg338 mice with identical clinical,
pathological, immunohistochemical and biochemical features. While this might potentially
indicate that sheep-adapted 87V and CH1641 are the same strain, profound divergences were
evident, as murine 87V was unable to infect Tg338 mice but was lethal for VM mice, while the
reverse was true for CH1641. These combined data suggest that: (i) murine 87V is stable and
retains its properties after passage in sheep; (ii) it can be isolated from sheep showing a
CH1641-like or a more conventional scrapie phenotype; and (iii) sheep-adapted 87V scrapie,
with conventional or CH1641-like phenotype, is biologically distinct from experimental CH1641
scrapie, despite the fact that they behave identically in a single transgenic mouse line.
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INTRODUCTION
Scrapie is the archetype of the transmissible spongiform
encephalopathies (TSEs) or prion diseases, which include
among others bovine spongiform encephalopathy (BSE),
chronic wasting disease of cervids and Creutzfeldt–Jakob
disease of humans. Classical scrapie (which is distinct
from atypical scrapie or Nor98) is a naturally occurring,
infectious and contagious disease of sheep and goats, first
reported more than 200 years ago (Schneider et al., 2008).
Unlike BSE, which is believed to be caused by a single,
unique agent (Bruce et al., 1994; 2002), the existence of
strain variation in scrapie has long been documented from
work performed in laboratory rodents (Bruce et al., 1991).
Thus, many strains of scrapie have been identified in mice,
which differ in clinical (incubation period) and pathological
(vacuolar lesion profile) characteristics (Fraser, 1976; Dick-
inson & Fraser, 1977) when isolated and passaged in the
same line of inbred mice (Bruce et al., 1991). Current
methods of strain typing in mice additionally include: (i)
assessment of the phenotype of disease-associated prion
protein (PrPd) accumulation in the brain by immunohisto-
chemistry (IHC), histoblotting or paraffin-embedded tissue
blotting (Bruce et al., 1994; Jeffrey et al., 2001; Lezmi et al.,
2006; Beck et al., 2010); and (ii) the characterization of the
3Present address: UC Davis School of Veterinary Medicine, One
Shields Ave, Davis, CA 95616, USA.
4Present address: The Roslin Institute and Royal (Dick) School of
Veterinary Studies, Easter Bush, Midlothian EH25 9RG, UK.
Abbreviations: BSE, bovine spongiform encephalopathy; IHC,
immunohistochemistry; p.i., post-inoculation; PrPd, disease-associated
PrP; PrPres, protease-resistant core of PrPd; TSE, transmissible
spongiform encephalopathy; WB, Western blotting; WT, wild type.
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biochemical profile of the protease-resistant core (PrPres) of
PrPd, usually by Western blotting (WB) (Somerville et al.,
1997; Kuczius et al., 1998; Baron et al., 2004).
One of themurine scrapie strains so far identified and charac-
terized is 87V. It was originally isolated from a case of scrapie
in a crossbred Cheviot/Border Leicester sheep after intracer-
ebral primary injection and subsequent passage in VM mice
homozygous for the prion allele Prnp b (previously called
Sinc p7; Bruce & Dickinson, 1979). 87V is considered stable
in terms of clinical and pathological phenotype when propa-
gated in VMmice. However, inoculation of the same original
sheep source in C57BL mice (homozygous for the Prnp a or
Sinc s7 allele) gave rise to a strain called 87A, which on sub-
sequent passages in the same mouse line showed sudden
and sporadic signs of instability resulting in two different
strains, 87A itself and ME7 (originally designated 7D; Bruce
& Dickinson, 1979). These findings suggest that either the
original sheep scrapie case contained a mixture of strains,
one of which was able to propagate only in one mouse line/
genotype (7D/ME7 in C57BL mice), or that an originally
single agent strain was capable of changing some of its prop-
erties as a result of passage in a particular mouse line, C57BL
in this case (Bruce & Dickinson, 1979). Murine 87V PrPres
exhibits similarities with BSE- and CH1641-derived PrPres
on WB analysis, in terms of glycoprofile (predominance of
the diglycosylated band), lowmolecular mass of the unglyco-
sylated band and lack of reactivitywithN-terminal antibodies
such as P4 (Kuczius & Groschup, 1999; Baron & Biacabe
2007; Baron et al., 2008). However, 87V PrPres is more
stable or resistant than BSE PrPres to proteinase K treatment
(Kuczius & Groschup, 1999).
The approach of natural sheep scrapie strain typing by
bioassay in mice has some drawbacks. One is that some scra-
pie isolates do not transmit efficiently to wild type (WT)
mice due to either the nature of the agent or to the so-
called ‘species barrier’ (Dickinson, 1976; Bruce & Fraser,
1991; Bruce et al., 2002). To try to overcome this problem,
transgenic mice have been developed that express ovine
PrP; among these are the TgOvPrP4 and Tg338 mice,
which express in homozygosity the ovine 136A154R171Q
and 136V154R171Q alleles, respectively (Crozet et al., 2001;
Vilotte et al., 2001; Laude et al., 2002). With this approach,
Baron & Biacabe (2007) succeeded in transmitting the
CH1641 experimental sheep scrapie source (Dickinson &
Fraser, 1977) to transgenic TgOvPrP4 mice, when previous
attempts to transmit this source to WT mice had failed
(Foster & Dickinson, 1988; Baron et al., 2004). Moreover,
on transmission to TgOvPrP4 mice, similarities were
found between sheep-derived CH1641 and mouse-derived
87V, in terms of: (i) attack rates and to a lesser extent incu-
bation periods; (ii) WB glycoprofiles; (iii) mobility of the
unglycosylated PrPres band; and (iv) differential reactivity
to the globular domain and N-terminal PrP antibodies in
WB (Baron & Biacabe, 2007). A different report on the
same transmissions indicated that similarities between
CH1641-like cases and 87V extended to IHC-demonstrable
PrPd types in brain (mostly extracellular fine particulate and
intraneuronal aggregates) and, to a lesser extent, vacuolar
lesion profiles and distribution (Bencsik & Baron, 2011).
The present report addresses the transmission back into VM
mice of 87V previously passaged in sheep (Siso´ et al., 2012)
with the aim of assessing the stability of the original murine
strain. Given the similarities between 87V and CH1641 that
have already been expounded, which were also observed in
the original murine 87V to sheep experiment (Siso´ et al.,
2012), this report also covers the outcome of inoculations
of Tg338 mice with the same sheep-derived 87V sources
and CH1641 ovine scrapie with the aim of further compari-
son between these two strains.
RESULTS
Clinical aspects of disease in mice: attack rates
(ARs) and survival times (STs)
All 10 VM mice inoculated with normal sheep brain hom-
ogenate were negative for PrPd by IHC or by WB (n55 in
each case) when killed due to old age [674+58 days post-
inoculation (p.i.), mean+SD] in the absence of clinical
signs. Equally, the 10 mice of the second passage, which
were inoculated with a brain homogenate from one nega-
tive VM mouse of the first passage, were all negative
when killed at the end of the experiment (set at 498 days
p.i.). Evidence of TSE infection was not detected by IHC
(n56) or WB (n54) in any of the 10 VM mice inoculated
with ovine CH1641 that either died or were clinically silent
when culled at 627+56 days p.i. (Table 1 and Fig. 1a).
ARs and STs for VMmice of the first and second passages are
detailed in Table 1 and illustrated in Fig. 1. For first passages,
ARswere 100 % forVMmice inoculatedwith themurine 87V
positive control and for those challenged with Suffolk AA-
derived inoculum (as all three sheep-derived 87V inocula
were from 154R171Q homozygotes, these sources are identified
by the codon 136 genotype throughout this report).However,
STs were significantly shorter (Pv0.001) for the murine
control (304+19 days p.i.) than for the Suffolk AA-passaged
87V (384+32 days p.i.). For first-passage VM mice inocu-
lated with Cheviot AA-derived 87V, ARs were significantly
lower (58 %; Pv0.01) when compared with the two previous
groups, and STs were also significantly longer (440+84 days
p.i.; Pv0.001 compared with murine 87V and Pv0.05 com-
pared with Suffolk AA-derived 87V). Only one mouse inocu-
lated with Cheviot VV-derived 87V succumbed to infection
with an ST of 391 days p.i. (AR 10 %, significantly lower
than the three previous groups: Pv0.001 compared with
themurine 87V positive control and with Suffolk AA-derived
87V and Pv0.05 compared with Cheviot AA-derived 87V).
In the second passages, ARs were 100 % for all four 87V
inoculations (three with inocula originally derived from
sheep and one with murine control). STs were also very simi-
lar between the four groups, with the only significant differ-
ence (Pv0.01) occurring between Cheviot AA-derived 87V
(313+13 days p.i.) and the murine control (298+6 days
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Table 1. Clinical aspects of the outcome of the experiment
AR, Attack rate in number of mice IHC or WB positive/number of mice surviving for long enough to be considered (see text) and percentage in
parentheses; ST, survival time in days post-inoculation expressed as mean¡SD. For statistical significance of differences, refer to text; NA, not
available.
Source of inoculum VM mice Tg338 mice
1st passage 2nd passage 1st passage
AR ST AR ST AR ST
Suffolk AA 87V 15/15 (100 %) 384¡32 15/15 (100 %) 306¡13 12/12 (100 %) 157¡16
Cheviot AA 87V 7/12 (58 %) 440¡84 14/14 (100 %) 313¡13 12/12 (100 %) 149¡7
Cheviot VV 87V 1/10 (10 %) 391 14/14 (100 %) 317¡46 12/12 (100 %) 148¡9
CH1641 (AA) 0/10 (0 %) 627¡56 NA NA 12/12 (100 %) 157¡3
Murine 87V 14/14 (100 %) 304¡19 10/10 (100 %) 298¡6 0/12 (0 %) 570¡169
NSB/NI* 0/10 674¡58 0/10 (0 %) 498¡0 0/12 (0 %) 588¡162
*NSB/NI, normal brain from an ARQ/ARQ sheep (VM mice) or non-inoculated (Tg338 mice).
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Fig. 1. Survival curves as percentages at various days p.i. of the different mouse groups [VM mice (a, b) and Tg338 mice (c)]
challenged intracerebrally with different 87V sources: black, murine control; sheep-derived: red, Suffolk AA; blue, Cheviot AA;
green, Cheviot VV; orange, CH1641. Arrows in (a) indicate mice selected for second passages in VM mice. Circles indicate the
number of days p.i. of PrPd/PrPres-negative mice dying after the first positive mouse in each group, which are included in the cal-
culation of ARs. A second passage in VM mice from the CH1641 inoculum was not attempted as all mice of the first passage
were negative. Data for VM mice inoculated with normal sheep brain and for non-inoculated Tg338 mice are not illustrated.
Sheep-passaged 87V and CH1641 scrapie
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p.i.). The lack of difference in ST between the murine control
and the Cheviot VRQ-derived 87V (317+46 days p.i.)
appeared to derive from the fact that one of the mice inocu-
lated with this source had a protracted ST (470 days p.i.; Fig.
1b), giving a high SD to this group.
Unlike VM mice, Tg338 mice did not succumb to inocu-
lation with the murine 87V control, while all of the mice
inoculated with CH1641 did, with STs similar (157+3 days
p.i.) to those of Suffolk AA-derived 87V (157+16 days p.i.)
and slightly but significantly longer (Pv0.05) than those of
Cheviot AA-derived (149+7 days p.i.) and Cheviot VV-
derived (148+9 days p.i.) 87V (Table 1 and Fig. 1c). ARs
for all sheep-derived 87V were also 100 %. Non-inoculated
Tg338 mice did not show any pathological or IHC evidence
of infection when killed at 588+162 days p.i.
Neuropathological features in mice inoculated
with murine 87V, sheep-derived 87V and CH1641
Vacuolar lesion profiles obtained at first and, particularly,
second passages in VM mice were very similar across all
three groups of sheep-derived 87V and were also similar to
those resulting from inoculation with the murine 87V posi-
tive control. In all cases, vacuolation was most prominent in
the thalamus and in all three white-matter areas scored, and
was least conspicuous in the cerebellum, hypothalamus and
cerebral cortex (Fig. 2a, b). Similarly, although different
from those in VM mice, vacuolar lesion profiles in Tg338
mice were almost identical among the three groups inocu-
lated with sheep-derived 87V and also between these and
mice challenged with CH1641 (Fig. 2c). In these mice,
vacuolation was most pronounced in the hypothalamus,
thalamus and medulla, while white-matter tracts were
almost completely unaffected.
The profiles of PrPd accumulation in the brains of VMmice at
first and second passage were also very similar, in terms of
both distribution and PrPd types, among the three mouse
groups inoculated with sheep-derived 87V and also between
these and the murine 87V control. Accumulation of PrPd
was widespread in the brain and was particularly prominent
in the septal area, hippocampus (with particular targeting of
theCA2 sector and the stratum lacunosummoleculare), thala-
mus and hypothalamus, midbrain (particularly lateral
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Fig. 2. Vacuolar lesion profiles in the different mouse groups [VM mice (a, b) and Tg338 mice (c)] challenged with the differ-
ent 87V sources: black, murine 87V control; sheep-derived: red, Suffolk AA; blue, Cheviot AA; green, Cheviot VV; orange,
CH164. There are no profiles for CH1641 in VM mice or for murine 87V in Tg338 mice as none of these mice developed
any evidence of TSE. There is no profile for the first passage of Cheviot VV-derived 87V in VM mice, as only one mouse
became clinically affected; this was confirmed by WB and the brain used for second-passage inoculation. Error bars are not
illustrated due to the similarity of profiles. G1–G9, grey-matter areas; W1–W3, white-matter areas. The y-axis shows the
evaluation of vacuolar lesions, which was scored from 0 to 5 (Fraser, 1976).
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geniculate body, substantia nigra and pontine nucleus) and
medulla (Fig. 3a). In the latter, fine particulate (sometimes
adopting a perineuronal arrangement), intraneuronal and
intraglial PrPd types predominated. PrPd aggregates were
also conspicuous in the cerebral cortex and in the granular
layer of the cerebellum, where they were mostly of the
coalescing/immature plaque PrPd type (Fig. 3a). In addition,
vascular and non-vascular mature PrPd plaques were present
in associationwith the needle track andwith the ventricles and
subarachnoidal space. The similarity inPrPd types throughout
the brainwas reflected in almost identical PrPd profiles at both
first (Fig. 3b) and second (Fig. 3c) passage.
Murine 87V
(a)
(b) (c)
Suffolk AA 87V Cheviot AA 87V Cheviot VV 87V
(i) (ii) (iii)
(iv) (v) (vi)
(vii) (viii) (ix) (x)
(xi) (xii) (xiii) (xiv)
50
40
30
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0
%
PrPd type
First passage in VM mice
ITNR ITGL STEL PART COAL PLAQ
50
40
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0
%
PrPd type
Second passage in VM mice
ITNR ITGL STEL PART COAL PLAQ
Fig. 3. Features of PrPd accumulation in the brains of VM mice. (a) Similarity of PrPd distribution and PrPd types throughout the
brain of mice at first (i–vi) and second (vii–xiv) passage regardless of the source of inoculum (as indicated in the column head-
ings). Note the prominent coalescing type in the cerebral cortex (i–iii) and diffuse fine particulate PrPd targeting the same areas
of the hippocampus (iv–vi), midbrain (vii–x) and medulla (xi–xiv). Images show IHC with the 2G11 PrP antibody and haematoxy-
lin counterstaining. (i) and (vii), 375 mm (i–vi); 750 mm (vii–xiv). (b, c) The marked similarity in PrPd types is reflected in the PrPd
profiles both at first (b) and second (c) passage. Error bars are not illustrated due to profile similarities. There are no images (a)
or a profile (b) for mice challenged at first passage with Cheviot VRQ-derived 87V, as only one mouse of this group was posi-
tive and was used for second-passage transmission. ITNR, intraneuronal; ITGL, intraglial (intra-microglial and intra-astrocytic
combined); STEL, stellate; PART, particulate; COAL, coalescing; PLAQ, plaques (vascular and non-vascular combined).
Sheep-passaged 87V and CH1641 scrapie
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In Tg338 mice, accumulation of PrPd in the brain was of a
markedly lower magnitude and had a more restricted distri-
bution than in VM mice. Thus, the cerebral and cerebellar
cortices, the septal area and the hippocampus were largely
unaffected, and PrPd types were only of the intraneuronal,
intraglial and fine particulate types, with absence of coales-
cing deposits or plaques (Fig. 4a). These three types of
PrPd accumulation were most conspicuous in the habenula,
hypothalamus, substantia nigra, vestibular complex, deep
cerebellar nuclei and all nuclei of the caudal medulla, and
were almost identical among the three sheep-derived 87V
sources and CH1641 (Fig. 4b), although this last source
resulted in generally lower PrPd brain magnitudes.
Biochemical features of PrPres from brains
of mice inoculated with murine 87V, sheep-
passaged 87V and CH1641
An illustration of representative WB results in VM mice is
given in Fig. 5(a). Differences in PrPres glycoprofiles were
not found between two successive passages of murine
87V, while first and second murine passages of Suffolk
AA-derived 87V differed (Pv0.05) in the proportion of
diglycosylated PrP. Differences between first and second
passages could not be tested for the Cheviot-derived 87V
as only one mouse brain was available for WB from pri-
mary passage of these two sources. When comparing the
glycoform ratios of second passages, the murine 87V con-
trol and the Cheviot VV-derived 87V source produced sig-
nificantly (Pv0.05) lower diglycosylated (*49–53 %) and
higher unglycosylated (*19–20 %) PrPres than the two
AA-derived (Suffolk and Cheviot) 87V sources (*59–
60 % and 12–13 %, respectively for di-and unglycosylated
PrPres; Fig. 5b).
Differences in molecular masses of the three different WB
bands in VMmice were not observed between the two succes-
sive passages of murine 87V or between the first and second
passage of Suffolk AA-derived 87V (results not shown).
Fig. 5(c) illustrates the absence of significant differences in
molecular masses of the three bands when the four sources
(i)
(a)
(b)
(Ii) (iii) (iv)
(v) (vi) (vii) (viii)
PrPd types
%
50
ITNR ITGL STEL PART COAL PLAQ
40
30
20
10
0
CH1641 AASuffolk AA 87V Cheviot AA 87V Cheviot VV 87V
Fig. 4. Features of PrPd accumulation in the brains of Tg338 mice. (a) Particulate PrPd in the arcuate and ventromedial hypo-
thalamic nuclei and the median eminence of mice challenged with the four sources (as indicated in the columns) (i–iv), and
particulate, intraneuronal and intraglial PrPd in the vestibular complex (v, vi) and deep cerebellar nuclei (vii, viii). (i), (v) and
(vii), 375 mm (i–iv); 150 mm (v, vi); 75 mm (vii, viii). IHC with 2G11 PrP antibody and haematoxylin counterstaining. (b) High
degree of similarity in PrPd profiles among the three sheep-derived 87V sources (red, Suffolk AA; blue, Cheviot AA; green,
Cheviot VV) and CH1641 (orange), with similar proportions of intracellular and fine particulate deposits. See Fig. 3 legend
for abbreviations. Error bars are not illustrated due to profile similarities.
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were compared (first and secondpassage combined; statistical
analyses not shown), which on average were 28.6–29.2 kDa
for the diglycosylated form, 24.0–24.4 kDa for the mono-gly-
cosylated form and 18.7–19.3 kDa for the unglycosylated
form.
In Tg338 mouse brains, WB with 6H4 antibody showed
low molecular masses of the unglycosylated band of all
three sheep-passaged 87V sources and CH1641 and also
absence of the PrPres signal with 12B2 antibody in
common with these four inocula (Fig. 5d).
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Fig. 5. WB characteristics of PrPres from mouse brains. (a) WB with SAF84 from second-passage VM mice inoculated with
the different 87V sources. Lanes: MW, molecular mass marker in kDa; 1–3, murine control; 4–6, Suffolk AA; 7–9, Cheviot
AA; 10–12, Cheviot VV. (b) Tri-blot representation of the proportion of di-, mono- and unglycosylated PrPres (results shown
as means¡SEM) of VM mice challenged with the different 87V sources. Open circles represent first passage and solid dia-
monds second passages of: black, murine control (n57 and n55, respectively); red, Suffolk AA (n57 and n57, respectively);
blue, Cheviot AA (n51 and n55, respectively); green, Cheviot VV (n51 and n57, respectively). Second-passage PrPres from
the murine control and Cheviot VV had significantly lower diglycosylated (,49–53 %) and higher unglycosylated
(,19–20 %) PrPres than second-passage PrPres from Suffolk AA and Cheviot AA sources (,59–60 % di- and 12–13 %
unglycosylated PrPres). (c) Molecular masses of the diglycosylated (squares), monoglycosylated (triangles) and unglycosylated
(diamonds) PrPres glycoforms; results shown as means¡SEM for the different 87V sources (first and second passages com-
bined): black, murine control (n512); red, Suffolk AA (n514); blue, Cheviot AA (n56); green, Cheviot VV (n58). (d) WB
characteristics of PrPres from brains of Tg338 mice (unless stated otherwise) inoculated with the different sources; left panel,
6H4 antibody; right panel 12B2 antibody. Lanes: MW, molecular mass marker in kDa; 1, classical scrapie from ARQ/ARQ
sheep; 2 and 6, murine 87V control (in VM mice, as this source did not infect Tg338 mice); 3, 4 and 7, Cheviot VV-, Suffolk
AA- and Cheviot AA-passaged 87V, respectively; 5 and 8, CH1641. Note the similar masses of the unglycosylated band and
the absence of signal with 12B2 in the three sheep-passaged 87V sources and CH1641.
Sheep-passaged 87V and CH1641 scrapie
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DISCUSSION
Inoculation of sheep-passaged 87V back into VM mice
apparently resulted in reisolation of the original murine
strain, irrespective of the sheep breed and PRNP genotype
or the disease phenotype in such sheep. This interpretation
is based on the clinical, histopathological and immunohis-
tochemical similarities of the disease in VM mice at second
passage between those inoculated with the three sheep
sources and the murine positive control used in the exper-
iment. ARs and STs obtained at second passage in this
experiment also agreed with those for 87V in VM mice
described in the literature (Bruce et al., 1976, 1991;
Fraser & Bruce, 1983). Additionally, the vacuolar lesion
profiles were similar to those described elsewhere (Bruce
& Dickinson, 1985; Kim et al., 1990; Beck et al., 2012;
Thackray et al., 2012), although white-matter vacuolation
in the last three of these reports was less pronounced
than in our experiment. Similarities with other studies
extend also to IHC-detectable PrPd aggregates, such as pla-
ques/coalescing deposits [Bruce & Fraser, 1975; Fraser,
1976; Fraser & Bruce, 1983; Bruce & Dickinson, 1985;
Gibson, 1986 (although these reports describe plaques
based on histopathological and not IHC examinations);
Beck et al., 2012; van Keulen et al., 2015] and fine particu-
late, intraneuronal and intraglial PrPd types [Jeffrey et al.,
1994a, b, 1996 (although some of these observations were
based on immunoelectron microscopy); Beck et al., 2012;
van Keulen et al., 2015]. In terms of the biochemical fea-
tures of PrPres in the brains of VM mice inoculated at
second passage with sheep-derived 87V, in some instances
(Cheviot VV) the glycoprofile was indistinguishable from
that of the murine control, while in others (AA sheep) it
showed a higher proportion of diglycosylated PrPres than
the murine controls but was similar to that described by
others (Somerville et al., 1997; Beck et al., 2012; van
Keulen et al., 2015). In this respect, it is perhaps note-
worthy that 87V isolated from field cases in the report by
Beck et al. (2012) and in another study (Thackray et al.,
2012) have all been from ARQ/ARQ sheep.
Reisolation of 87V at second passage in VM mice was
achieved despite some phenotypic divergences within the
three sheep groups, particularly in terms of the biochemical
properties of brain PrPres and in primary transmission
results. Suffolk AA-adapted 87V, with a conventional scra-
pie phenotype, transmitted best to VM mice, showing only
slightly longer STs than those in the murine 87V control,
which could be attributable to the species barrier effect.
The other two 87V-infected sheep groups, Cheviot AA
and VV, which developed a CH1641-like phenotype,
showed less-efficient transmission on primary passage
back to VM mice, in terms of both AR and ST; of these
two groups, the lowest transmissibility of the Cheviot
VV-adapted 87V could be due to PRNP genotypic differ-
ences with VM mice, which are AA at codon 132 (homolo-
gous to ovine codon 136). This could suggest that the
PRNP genotype of the sheep from which 87V was originally
isolated (Bruce & Dickinson, 1979) was ARQ/ARQ
(genotyping was not available at the time) rather than
VRQ/VRQ, which would fit with the already-mentioned
recent isolation of 87V from field cases of scrapie in
ARQ/ARQ sheep (Beck et al., 2012; Thackray et al.,
2012). It would also appear that isolation of 87V in VM
mice is more readily achievable from sheep with conven-
tional scrapie phenotype, but whether the above-men-
tioned field cases showed similar immunohistochemical
and biochemical profiles to the Suffolk AA sheep of the
present experiment is unknown, as such details are not
included in these publications. This is another pitfall of
classical strain typing by bioassay: the lack of phenotypic
characterization of the original scrapie sources. Previous
bioassay studies frequently define ‘strains’ by the outcome
of the bioassay, which in itself is an interaction between the
infectious agent from an outbred species and the murine
host. Without data on the original donor phenotype, it is
difficult or impossible to read back bioassay outcomes to
the original donor strain.
An alternative explanation for the relatively low transmissi-
bility of sheep-adapted 87V to mice on primary passage
could be that such transmissions were not from the agent
amplified during the ovine infection but were from residual
murine inoculum. We believe that this possibility is highly
unlikely as: (i) specific attempts to detect residual inocu-
lum in sheep intracerebrally infected with sheep scrapie
(Hamir et al., 2002) or cattle BSE (Siso´ et al., 2009) gave
negative results; (ii) the sheep inocula for intracerebral
challenge were prepared from the medulla oblongata,
while the donor sheep had been inoculated in the parietal
cortex; and (iii) transmission to VM mice at primary
inoculation was most successful from the Suffolk AA-
derived 87V inoculum, i.e. from the donor sheep with
the longest survival time of all three donors (see Methods),
and was therefore least likely to contain residual inoculum.
Another notable point is the fact that a cloned strain, 87V
in this case, which was later recovered, can produce disease
with different PrPres biochemical properties in sheep of the
same ARQ/ARQ genotype but of a different breed, such as
Suffolk and Cheviot (Siso´ et al., 2012). It is unlikely that the
genetic difference at codon 141 (leucine homozygosity for
Suffolk sheep and phenylalanine, either in homo- or het-
erozygosity for Cheviot sheep) can be responsible for the
different IHC and WB reactivity with P4, as the amino
acid sequence targeted by this mAb excludes codon 141
and as changes in another codon (AA or VV at codon
136 between the two groups of Cheviots) does not alter
P4 immunoreactivity (Siso´ et al., 2012). Phenotypic varia-
bility of classical scrapie in sheep of the same ARQ/ARQ
genotype has been documented and interpreted as indica-
tive of the existence of different strains in the field (Gon-
za´lez et al., 2010). This interpretation may need to be
revised, as it would appear that genetic factors other than
the PRNP gene can be responsible for some degree of phe-
notypic divergence of disease in sheep of the same ARQ/
ARQ genotype infected with a cloned, presumably
unique, strain.
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The results of the transmissions to Tg338 mice were intri-
guing. On the one hand, all three sheep-derived 87V
sources and CH1641: (i) transmitted with high efficiency
and similar short incubation periods; (ii) gave rise to indis-
tinguishable vacuolar lesion profiles and types and distri-
bution of PrPd in the brain; and (iii) provided PrPres
with identical biochemical properties. This would suggest
some sort of relationship between 87V and CH1641,
which is in sharp contradiction with CH1641 being
unable to infect VM mice in this study but efficiently
infecting Tg338 mice, while the opposite was true for the
murine 87V control.
The very low rates or absence of transmission of the exper-
imental CH1641 scrapie source to WT mice have been
repeatedly stated (Foster & Dickinson, 1988; Hope et al.,
1999) and clearly documented for C57BL mice (Prnp a/a;
Baron et al., 2004), which is in agreement with our results
in VM mice (Prnp b/b). When 87V was inoculated into Che-
viot AA and Cheviot VV sheep, it caused disease with an
immunohistochemical and biochemical ‘CH1641-like’ pat-
tern (Siso´ et al., 2012), and on transmission to Tg338 mice
these two sources were indistinguishable from experimen-
tal CH1641. However, Cheviot-derived ‘CH1641-like’
87V is different from CH1641 because it transmits to WT
VM mice, as do other ‘CH1641-like’ scrapie isolates from
ARQ/ARQ sheep to C57BL/6 mice (Vulin et al., 2012).
This suggests that caution is required when interpreting
the results of transmissions to Tg338 mice in so far as
the definition of strains is concerned. Moreover, the failure
of Tg338 mice to develop any evidence of infection when
inoculated with murine 87V was surprising. This might
be the effect of the ‘species barrier’, as these mice express
ovine VRQ PrP. However, this is a weak argument because:
(i) murine 87V can efficiently infect sheep of the VRQ/
VRQ genotype, at least by a combined intracerebral/subcu-
taneous route (Siso´ et al., 2012); and (ii) other ovine trans-
genic mice such as TgOvPrP4 (expressing ARQ ovine PrP)
are susceptible to 87V infection (Baron et al., 2004; Baron
& Biacabe, 2007).
Several ‘CH1641-like’ natural scrapie isolates transmitted
to TgOvPrP4 mice have revealed biochemical similarities
between these isolates, experimental CH1641 and murine
87V, which has allowed differentiation between them and
experimental ovine and murine classical BSE and L-type
BSE (Baron & Biacabe, 2007; Baron et al., 2008). Simi-
larities between CH1641, ‘CH1641-like’ and 87V also
extend to patterns of PrPd/PrPres deposition in the brain
and, to a lesser extent, the vacuolar lesion profiles (Bencsik
& Baron, 2011). Transmission to C57BL and RIII mice was
attempted from one of the ‘CH1641-like’ isolates with
negative results (Baron & Biacabe, 2007); it is perhaps
worth noting that this isolate came from a VRQ/VRQ
sheep, as did the original CH1641 source (Jeffrey et al.,
2006).
In summary, the 87V murine scrapie cloned strain caused
disease in sheep with two different phenotypes, a
‘CH1641-like’ phenotype in ARQ/ARQ and VRQ/VRQ
Cheviot sheep and a more conventional classical scrapie
phenotype in ARQ/ARQ Suffolk sheep. Although recovery
at first passage back into VM mice was most successful
from the Suffolk AA source, the original 87V strain was
recovered from all three sources upon second passage, indi-
cating the stability of the murine strain. However, although
transmission to Tg338 mice would indicate that sheep-
passaged 87V and CH1641 are the same agent, failure to
transmit CH1641 to VM mice and murine 87V to Tg338
in this study indicates that CH1641 is not the origin of
87V and, together with other published evidence, that
this murine strain may be related to isolates of ARQ/ARQ
origin.
METHODS
Experimental design. The outcome of the first part of the study, in
which sheep of two different breeds and PRNP genotypes were
inoculated with murine scrapie strain 87V, has already been reported
(Siso´ et al., 2012). Briefly, ARQ homozygous Suffolk and Cheviot
sheep and VRQ homozygous Cheviot sheep succumbed to murine
87V infection with a 100 % AR after combined oral, intracerebral and
subcutaneous inoculation. Two disease phenotypes were observed: (i)
Suffolk AA sheep (n53) developed a ‘conventional’ scrapie pheno-
type, with predominance of intracellular PrPd in brain (Fig. 6a),
which was demonstrable with C-terminal and N-terminal antibodies
(Siso´ et al., 2012); on WB analyses, PrPres was also detected with
SAF84 and P4 antibodies (Fig. 6b); and (ii) Cheviot AA and Cheviot
VV sheep (n53 each) developed a ‘CH1641-like’ phenotype (Stack
et al., 2002; Jeffrey et al., 2006), also with predominance of intra-
cellular PrPd in brain, which was not demonstrable with N-terminal
antibodies (Siso´ et al., 2012); on WB analyses of brain extracts, PrPres
was detected with SAF84 but not with P4 (Fig. 6b) and the molecular
mass of the unglycosylated band was lower than that observed in
brains from Suffolk AA sheep (Fig. 6c).
In the experiment covered by the present report, the stability of the
original 87V murine strain was tested by passage back into VM mice
(Fig. 7). For this purpose, three sheep from the first part of the ex-
periment were selected; they had the following characteristics in terms
of PRNP genotype, ST and total magnitude of PrPd in brain: (i)
Suffolk AA with no other polymorphisms, 719 days and 7.9; (ii)
Cheviot AA homozygous for phenylalanine at codon 141, 452 days
and 5.3; and (iii) Cheviot VV with no other polymorphisms, 663 days
and 11.5. The PrPd IHC profiles and WB features of the three 87V-
infected sheep selected for the mouse bioassay are given in Fig. 6,
which is representative of all sheep within the three groups.
Homogenates of medulla from each of these three sheep were pre-
pared as a 10 % (w/v) dilution in PBS, treated at 56 uC for 30 min and
checked for sterility by routine microbiological techniques. Twenty
microlitres of each sheep-derived inoculum was injected intracere-
brally in three groups of 15 VM mice; another group of 15 VM mice
was similarly challenged with murine 87V inoculum (positive con-
trol), and a group of 10 VM mice was inoculated intracerebrally with
a 10 % (w/v) homogenate of normal brain from an ARQ/ARQ sheep
(negative control). For the second passage, one mouse from each
inoculation group was selected (normally a mouse with a survival
time close to the mean of the group) and its brain prepared as a 10 %
(w/v) homogenate in PBS, 20 ml of which was injected intracerebrally
in groups of either 15 mice (for the three inocula originating from
sheep-derived brain material) or 10 mice (for the positive and
negative controls).
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In view of the similarities in disease phenotype of some of the sheep-
adapted 87V cases and CH1641 (see above), five groups of 12 Tg338
mice (Laude et al., 2002) were each inoculated with the three sheep-
derived 87V inocula, with the murine 87V control and with CH1641
from an ARQ/ARQ sheep. A further group of 12 non-inoculated
Tg338 mice were monitored for their lifespan to assess the develop-
ment of any disease phenotype from overexpression of the transgene.
Inoculation of Tg338 mice was done only at first passage as was the
intracerebral injection of a further group of 10 VM mice with CH1641
ovine scrapie (Fig. 7). Inoculations of Tg338 mice were done with the
same inocula and followed the same methodology as for VM mice.
All experimental procedures were approved by the ethics committees
of the Moredun Research Institute and the Roslin Institute and car-
ried out under appropriate UK Home Office project and personal
licences. Mice were monitored daily for clinical signs compatible with
a TSE or intercurrent illness. At this point, or at the end of the study,
mice were killed humanely following Home Office regulations. All
mice were subjected to the same laboratory examinations.
Laboratory examinations. From each experimental group, brains
from approximately half of the mice were fixed in 10 % buffered
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Fig. 6. Immunohistochemical and biochemical features of the three sheep-derived 87V inocula used for intracerebral injection
in mice. (a) PrPd profiles in the brain of Suffolk AA (red), Cheviot AA (blue) and Cheviot VV (green) sheep infected with 87V,
expressed as percentage of each PrPd type over total PrPd. The types considered were: ITNR, intraneuronal; ITAS, intra-
astrocytic; ITMG, intramicroglial; STEL, stellate; SBPL, subpial; SBEP, subependymal; PRVS, perivascular; PVAC, perivacuo-
lar; PART, particulate; LINR, linear; PNER, perineuronal; EPEN, ependymal; NVPL, non-vascular plaques; and VSPL, vascular
plaques. Note the predominance of intracellular PrPd and almost complete restriction of extracellular PrPd to fine particulate
deposits. (b) WB profiles with PrP antibodies SAF84 (top panel) and P4 (bottom panel) of (lanes): 1, ARQ/ARQ sheep BSE;
2, ARQ/ARQ sheep natural scrapie; 3, VRQ/VRQ sheep natural scrapie; 4–6, Cheviot VV, Cheviot AA and Suffolk AA
sheep, respectively, infected with 87V. Note the presence of a further lower-molecular-mass band in the three sheep-derived
87V sources, and also the lower molecular mass of the unglycosylated band and the greatly diminished signal with P4 for
sheep BSE and the two Cheviot-derived 87V sources, which contrasts with the Suffolk-derived 87V and classical scrapie
cases. (c) WB with SAF84 after PNGase treatment of brain homogenates of (lanes): 1, ARQ/ARQ sheep natural scrapie; 2,
ARQ/ARQ sheep BSE; 3; ARQ/ARQ sheep CH1641; 4–6, Cheviot VV, Cheviot AA and Suffolk AA sheep, respectively,
infected with 87V. Note the higher molecular mass of unglycosylated PrPres (,20 kDa) from 87V-infected Suffolk AA sheep
compared with the 87V-infected Cheviot sources.
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Fig. 7. Schematic representation of the experimental design. Mu,
murine. NSB, normal sheep brain.
L. Gonza´lez and others
3712 Journal of General Virology 96
Downloaded from www.microbiologyresearch.org by
IP:  129.215.250.95
On: Wed, 17 Feb 2016 09:33:32
formalin for histopathological and IHC examinations and the other
half was frozen at 280 uC for WB analyses.
Formalin-fixed brains were trimmed to obtain the standard areas for
the assessment of vacuolar lesion profiles (Fraser, 1976), including
nine grey-matter areas (G1–G9) and three white-matter areas (W1–
W3). Trimmed tissue specimens were processed routinely, embedded
in paraffin wax, cut to 4 mm thickness, dewaxed, rehydrated by
standard procedures, and stained with haematoxylin and eosin for
evaluation of vacuolar lesions, which were scored from 0 to 5 (Fraser,
1976).
For IHC demonstration of PrPd accumulation, serial sections of the
same wax blocks were subjected to antigen retrieval and quenching of
hydrogen peroxide, as described previously (Gonza´lez et al., 2002,
2005); non-specific antigen blocking was done with a Mouse on
Mouse kit liquid protein concentrate solution (Vector Laboratories).
Tissue sections were then incubated with the primary mAb 2G11
(Novus Biologicals); the subsequent steps of the IHC procedure
were performed using a commercial immunoperoxidase technique
(Vector-Elite ABC kit, Vector Laboratories) following the manu-
facturer’s instructions and sections were finally counterstained with
Mayer’s haematoxylin. The magnitude of PrPd accumulation was
scored from 0 (absent) to 3 (severe) in the following brain areas:
(i) frontal cortex, corpus striatum and basal ganglia; (ii) tempor-
oparietal cortex, hippocampus, thalamus and hypothalamus; (iii)
midbrain; and (iv) cerebellar cortex, deep cerebellar nuclei and
medulla oblongata. The PrPd types observed and considered to con-
struct the PrPd profiles were the intraneuronal, intraglial (intra-
microglial and intra-astrocytic combined), stellate, fine particulate,
coalescing and plaques (vascular and non-vascular combined). The
histomorphology of these PrPd types has been described elsewhere
(Gonza´lez et al., 2002, 2005); plaques were only considered as such
when they showed a homogeneous core and a radiate periphery
(mature plaques), while in the absence of these features the dense
accumulations of PrPd were termed ‘coalescing’, without prejudice to
them actually corresponding to primitive plaques (Jeffrey et al.,
1994b, 1996). The overall score for each PrPd type was calculated as
the mean of the scores in the different brain areas and the total brain
PrPd as the sum of the mean scores for each PrPd type; the PrPd
profile was then expressed as the percentage of each PrPd type con-
tributing to total brain PrPd.
WB analyses on VM mouse brains were performed as described
previously in detail for sheep brain samples (Gonza´lez et al., 2012;
Siso´ et al., 2012). Membranes were probed using the SAF84 mAb (R-
Biopharm) and the relative intensities of the di-, mono- and ungly-
cosylated bands of PrPres and molecular masses of the unglycosylated
band were measured for comparison between experimental groups.
WB analyses on Tg338 mouse brains were carried out as described
previously (Jeffrey et al., 2006), and parallel membranes were blotted
with 6H4 (Prionics AG) and 12B2 (from J. P. M. Langeveld, Central
Veterinary Institute, Lelystad, The Netherlands) antibodies to allow
discrimination in PrPres truncation sites between different mouse
groups.
Data analysis. In this report, AR figures were calculated disregarding
those mice that, within each group, died earlier than the first mouse
showing indication of TSE infection by either IHC or WB. Similarly,
in the calculation of STs, only those mice with neurological signs of
IHC- or WB-confirmed TSE were included.
Differences in ARs between the different mouse groups were analysed
by Fisher’s exact test and those in STs by unpaired t-tests (GraphPad
Prism; GraphPad Software). Unpaired t-tests were also applied to the
comparison of WB glycoprofiles and molecular masses of the di-,
mono- and unglycosylated PrPres bands between the different ex-
perimental groups.
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